Table 3.

AEs Related to Tested Products in the ITT Population

	ALGINATE, n = 52		NPWT, n = 55
Adverse Event	Aes, n	Patients, n (%)	Aes, n	Patients, n (%)
At least one AE	0	0 (0)	14	13 (23.6)
Severe pain	0	0 (0)	5	5 (9.1)
Hemorrhage (one serious*)	0	0 (0)	4	3(5.5)
Skin irritation	0	0 (0)	2	2(3.6)
Infection	0	0 (0)	2	2(3.6)
Joint ankylosis	0	0 (0)	1	1(1.8)

*Blood loss of 300 mL.